132 related articles for article (PubMed ID: 36441107)
1. Treatment response in acute myeloid leukaemia-Clues in the biopsy core.
Aguilar Navarro AG; Tikhonova AN
Br J Haematol; 2023 Mar; 200(6):691-693. PubMed ID: 36441107
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomics of acute myeloid leukaemia core bone marrow biopsies reveals distinct therapy response-specific osteo-mesenchymal profiles.
Treaba DO; Bonal DM; Chorzalska A; Castillo-Martin M; Oakes A; Pardo M; Petersen M; Schorl C; Hopkins K; Melcher D; Zhao TC; Liang O; So EY; Reagan J; Olszewski AJ; Butera J; Anthony DC; Rintels P; Quesenberry P; Dubielecka PM
Br J Haematol; 2023 Mar; 200(6):740-754. PubMed ID: 36354085
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
Winfield DA; Polacarz SV
J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
[No Abstract] [Full Text] [Related]
4. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow biopsy changes in acute myeloid leukaemia. I: Observations before chemotherapy.
Islam A; Catovsky D; Goldman JM; Galton DA
Histopathology; 1985 Sep; 9(9):939-57. PubMed ID: 3864727
[TBL] [Abstract][Full Text] [Related]
6. Plastic embedded core biopsy: a complementary approach to bone marrow aspiration for diagnosing acute myeloid leukaemia.
Islam A; Frisch B; Henderson ES
J Clin Pathol; 1989 Mar; 42(3):300-6. PubMed ID: 2649520
[TBL] [Abstract][Full Text] [Related]
7. Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia.
Ladikou EE; Sivaloganathan H; Pepper A; Chevassut T
Curr Oncol Rep; 2020 Feb; 22(3):27. PubMed ID: 32048054
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease.
Roberts MM; Juttner CA; To LB; Kimber RJ
Leuk Res; 1988; 12(10):817-21. PubMed ID: 3199841
[TBL] [Abstract][Full Text] [Related]
9. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J
Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561
[TBL] [Abstract][Full Text] [Related]
10. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
11. Over expression of ubiquitin-conjugating enzyme E2O in bone marrow mesenchymal stromal cells partially attenuates acute myeloid leukaemia progression.
Tian C; Chen Z; Wang L; Si J; Kang J; Li Y; Zheng Y; Gao Y; Nuermaimaiti R; You MJ; Zheng G
Br J Haematol; 2023 Feb; 200(4):476-488. PubMed ID: 36345807
[TBL] [Abstract][Full Text] [Related]
12. Value of long-core biopsy in the detection of discrete bone marrow lesions.
Islam A; Henderson ES
Histopathology; 1988 Jun; 12(6):641-8. PubMed ID: 3166450
[TBL] [Abstract][Full Text] [Related]
13. Proposal for a classification of acute myeloid leukaemia based on plastic-embedded bone marrow biopsy sections.
Islam A
Leuk Res; 1993 May; 17(5):421-7. PubMed ID: 8501969
[TBL] [Abstract][Full Text] [Related]
14. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis of a microRNA signature for poor prognosis suggests a microRNA-controlled stemness pathway in paediatric acute leukaemia.
Erkeland SJ
Br J Haematol; 2023 Jul; 202(1):11-12. PubMed ID: 36994809
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of bone marrow MUC4 expression in acute myeloid leukaemia.
Abdelhady AS; Abdel Hamid FF; Hassan NM; Ibrahim DM
Br J Biomed Sci; 2020 Oct; 77(4):202-207. PubMed ID: 32270747
[No Abstract] [Full Text] [Related]
17. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction.
Tuzuner N; Cox C; Rowe JM; Bennett JM
Leuk Res; 1994 Aug; 18(8):559-64. PubMed ID: 8065157
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
[TBL] [Abstract][Full Text] [Related]
19. Impact of Day 14 Bone Marrow Biopsy on Re-Induction Decisions and Prediction of a Complete Response in Acute Myeloid Leukemia Cases.
Alsaleh K; Aleem A; Almomen A; Anjum F; S Alotaibi G
Asian Pac J Cancer Prev; 2018 Feb; 19(2):421-425. PubMed ID: 29479992
[TBL] [Abstract][Full Text] [Related]
20. Is a nadir bone marrow required and, if so, what to do with residual disease?
Luger SM
Best Pract Res Clin Haematol; 2011 Dec; 24(4):527-32. PubMed ID: 22127316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
